Correlation Between Edgewise Therapeutics and Vaxcyte

Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Edgewise Therapeutics and Vaxcyte, you can compare the effects of market volatilities on Edgewise Therapeutics and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Vaxcyte.

Diversification Opportunities for Edgewise Therapeutics and Vaxcyte

0.67

Correlation Coefficient

Edgewise Therapeutics  Vaxcyte

Poor diversification

The 3 months correlation between Edgewise and Vaxcyte is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Vaxcyte go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Vaxcyte

Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Vaxcyte. In addition to that, Edgewise Therapeutics is 1.26 times more volatile than Vaxcyte. It trades about -0.42 of its total potential returns per unit of risk. Vaxcyte is currently generating about -0.2 per unit of volatility. If you would invest  8,949  in Vaxcyte on October 16, 2024 and sell it today you would lose (832.00) from holding Vaxcyte or give up 9.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Edgewise Therapeutics  vs.  Vaxcyte

Edgewise Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Edgewise Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Vaxcyte

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Edgewise Therapeutics and Vaxcyte

The main advantage of trading using opposite Edgewise Therapeutics and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.

The idea behind Edgewise Therapeutics and Vaxcyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.